Clinical Trials
22 trialsMolecular Profiling Project
National Cancer Centre, Singapore
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
PANDA-VAC
UNC Lineberger Comprehensive Cancer Center
Study of Outcomes of Radiofrequency Ablation of Lung Tumors
University of Pittsburgh
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Cancer Research UK
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
H. Lee Moffitt Cancer Center and Research Institute
TOP 2301: Neoadjuvant Chemo for NSCLC
Duke University
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
University of Maryland, Baltimore
Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4
Stanford University
Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening Clinics
Dartmouth-Hitchcock Medical Center
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
RIM
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
PROS-CONS
National Institute for Tuberculosis and Lung Diseases, Poland
Guangzhou Women's Health Cohort Study (GWHCS)
Guangzhou Women and Children's Medical Center
Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer
Tongji Hospital
Lung Cancer Rehabilitation After Medical Treatment
Nantong University
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Roger Williams Medical Center
Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)
Tianjin Medical University Cancer Institute and Hospital
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
WiSP Wissenschaftlicher Service Pharma GmbH
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
King Faisal Specialist Hospital & Research Center
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
Medical University of Gdansk